Male Breast Cancer Completed Phase 1 Trials for Bavituximab (DB05136)

Back to Male Breast Cancer

Also known as: Breast Cancer, Male / Breast Cancer - Male / Breast cancer male / Cancer of male breast / Malignant neoplasm of male breast (disorder) / Carcinoma of male breast (disorder) / Breast cancer male NOS

Indication	Status	Phase
DBCOND0028546 (Male Breast Cancer)	Completed	1

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT01288261	Paclitaxel and Bavituximab in Treating Patients With HER2-Negative Metastatic Breast Cancer	Treatment	Bavituximab (DB05136) Paclitaxel (DB01229)